biopharmadealmakers.nature.com rapport :   Visitez le site

Données techniques du biopharmadealmakers.nature.com

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte biopharmadealmakers.nature.com.Actuellement, hébergé dans Singapore et son fournisseur de services est CloudFlare Inc. .

the related websites

domaine	Titre
biopharmadealmakers.nature.com	biopharma dealmakers | biopharma dealmakers is the leading professional network for life science com
edwinurrutia2.page.tl	edwinurrutia2 - register to biopharma dealmakers

tv-programme.com happyend.life the-minecraft.fr swissline.swisslife.fr jeux.fr swisslife.fr amazon.fr sofos.life msn.com livefoot.fr 

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé cloudflare contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

DNS

HtmlToText

menu a nature research service biopharma dealmakers search search visit / register sign in deal trends , cns our november 2018 edition is live raveena bhambra nov 01, 2018 deal trends read our september 2018 edition raveena bhambra sep 10, 2018 june 2018 protecting biotech ip to support deal value biopharma dealmakers jun 07, 2018 infectious diseases , june 2018 ebbs and flows in the infectious disease market biopharma dealmakers jul 11, 2018 join biopharma dealmakers today access exclusive expertise - for free! register × invite someone full name * email address * close send invitation latest content how to attract a biopharma partner premium content editorial content november 2018 how to attract a biopharma partner biopharma dealmakers nov 20, 2018 trends in neuroscience dealmaking premium content editorial content deal trends , cns , november 2018 trends in neuroscience dealmaking biopharma dealmakers nov 12, 2018 our november 2018 edition is live editorial content deal trends , cns our november 2018 edition is live raveena bhambra nov 01, 2018 the evolution of bioelectronic medicine sponsor content the evolution of bioelectronic medicine setpoint medical oct 05, 2018 the accelerating rise of bispecific antibodies outside of oncology editorial content september 2018 the accelerating rise of bispecific antibodies outside of oncology biopharma dealmakers sep 28, 2018 new frontiers in immuno-oncology premium content editorial content september 2018 new frontiers in immuno-oncology biopharma dealmakers sep 21, 2018 regenerative medicine becomes a reality premium content editorial content september 2018 regenerative medicine becomes a reality biopharma dealmakers sep 12, 2018 read our september 2018 edition editorial content deal trends read our september 2018 edition raveena bhambra sep 10, 2018 nordic life science days 2018, the region’s premier partnering event, returns to stockholm editorial content nordic life science days 2018, the region’s premier partnering event, returns to stockholm raveena bhambra jul 17, 2018 ebbs and flows in the infectious disease market premium content editorial content infectious diseases , june 2018 ebbs and flows in the infectious disease market biopharma dealmakers jul 11, 2018 explore partnering with sanofi pasteur sponsor content june 2018 explore partnering with sanofi pasteur sanofi pasteur jul 05, 2018 sponsor content bioelectronic medicine: targeting inflammatory disease with electricity - clinical results in ra and crohn’s, looking ahead at ms setpoint medical jun 15, 2018 protecting biotech ip to support deal value premium content editorial content june 2018 protecting biotech ip to support deal value biopharma dealmakers jun 07, 2018 sponsor content explore partnering with sanofi pasteur sanofi pasteur jun 07, 2018 read our bumper june 2018 issue editorial content deal trends , june 2018 read our bumper june 2018 issue raveena bhambra jun 04, 2018 falling walls science start-up of the year: call for nominations! editorial content falling walls science start-up of the year: call for nominations! raveena bhambra may 31, 2018 editions see all march 2017 14 contributions june 2017 25 contributions medtech 2017 12 contributions november 2016 16 contributions using biopharma dealmakers all about how to get the most from the biopharma dealmakers website, whether you are a sponsoring company or a member. view topic editorial content using biopharma dealmakers follow us on twitter biopharma dealmakers has just joined twitter. follow us for details of our latest content and partnering news stories. raveena bhambra mar 31, 2016 why share? premium content using biopharma dealmakers why share? jen thoroughgood oct 20, 2015 why follow? premium content using biopharma dealmakers why follow? jen thoroughgood oct 20, 2015 medtech dealmakers all the features from the latest edition of medtech dealmakers . view topic medtech dealmaking and financing trends in 2017 premium content editorial content medtech dealmakers , medtech may 2018 medtech dealmaking and financing trends in 2017 biopharma dealmakers may 18, 2018 diagnostics dealmaking in the past year premium content editorial content medtech dealmakers , medtech 2017 diagnostics dealmaking in the past year biopharma dealmakers may 05, 2017 medtech dealmaking and financing trends in 2016 premium content editorial content medtech dealmakers , medtech 2017 medtech dealmaking and financing trends in 2016 biopharma dealmakers may 04, 2017 deal trends the latest from biopharma dealmakers on trends in dealmaking. view topic trends in neuroscience dealmaking premium content editorial content deal trends , cns , november 2018 trends in neuroscience dealmaking biopharma dealmakers nov 12, 2018 our november 2018 edition is live editorial content deal trends , cns our november 2018 edition is live raveena bhambra nov 01, 2018 read our september 2018 edition editorial content deal trends read our september 2018 edition raveena bhambra sep 10, 2018 cns the latest from biopharma dealmakers on companies, research and deals in the cns field. view topic trends in neuroscience dealmaking premium content editorial content deal trends , cns , november 2018 trends in neuroscience dealmaking biopharma dealmakers nov 12, 2018 our november 2018 edition is live editorial content deal trends , cns our november 2018 edition is live raveena bhambra nov 01, 2018 deals round up – january 1st-15th 2018 editorial content deal trends , cns deals round up – january 1st-15th 2018 raveena bhambra jan 15, 2018 drug development the latest from biopharma dealmakers on companies, research and deals in the drug development field. view topic sponsor content drug development cyto-mine: an integrated, automated antibodyresearch platform with crispr–cas9 potential sphere fluidics sep 05, 2017 sponsor content drug development taking a patient-first, precision medicine approach to orphan drug development epygenix therapeutics, inc. jun 02, 2017 free nature.com webcast: new innovations in drug delivery technology editorial content drug development free nature.com webcast: new innovations in drug delivery technology carmen ramirez mar 07, 2017 academic/non-profit organisation the latest from biopharma dealmakers on establishments, research and deals from academic and non-profit organisations. view topic opening up academic partnerships premium content editorial content deal trends , academic/non-profit organisation , june 2016 opening up academic partnerships biopharma dealmakers aug 31, 2016 sponsor content academic/non-profit organisation , june 2016 fixing a critical disconnect in drug discovery drug discovery unit, university of dundee may 25, 2016 sponsor content academic/non-profit organisation , june 2016 ulster university: excellence in capabilities and innovation ulster university may 25, 2016 oncology the latest from biopharma dealmakers on companies, research and deals in the oncology field. view topic trends in oncology dealmaking premium content editorial content deal trends , oncology , march 2018 trends in oncology dealmaking biopharma dealmakers mar 05, 2018 our march 2018 issue is live. editorial content oncology , march 2018 our march 2018 issue is live. raveena bhambra mar 05, 2018 sponsor content oncology changing the fate of cellular immunotherapy fate therapeutics nov 24, 2017 gastrointestinal the latest from biopharma dealmakers on companies, research and deals in the gastrointestinal field. view topic sponsor content gastrointestinal bringing cures for gastrointestinal disorders within reach curileum discovery ltd mar 02, 2017 read our march 2017 issue. editorial content dermatology , gastrointestinal , oncology , march 2017 read our march 2017 issue. raveena bhambra mar 01, 2017 dealmaking for inflammatory disorders premium content editorial content gastrointestinal , june 2016 dealmaking for inflammatory disorders biopharma dealmakers jun 27, 2016 dermatology the latest from biopharma dealmaker

Analyse PopURL pour biopharmadealmakers.nature.com

https://biopharmadealmakers.nature.com/users/19878-aspyrian-therapeutics
https://biopharmadealmakers.nature.com/users/69928-abl-bio
https://biopharmadealmakers.nature.com/users/sign_in
https://biopharmadealmakers.nature.com/rooms/166-medtech-2017
https://biopharmadealmakers.nature.com/users/42381-qurient-co-ltd
https://biopharmadealmakers.nature.com/users/61238-isoplexis
https://biopharmadealmakers.nature.com/users/2639-andrew-marshall
https://biopharmadealmakers.nature.com/users/33730-temple-therapeutics
https://biopharmadealmakers.nature.com/users/9880-biopharma-dealmakers/posts/39029-new-frontiers-in-immuno-oncology
https://biopharmadealmakers.nature.com/channels/253-deal-trends

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

Domain Name: NATURE.COM
Registry Domain ID: 1716459_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.corporatedomains.com
Registrar URL: http://www.cscglobal.com/global/web/csc/digital-brand-services.html
Updated Date: 2016-08-06T05:54:55Z
Creation Date: 1994-08-11T04:00:00Z
Registry Expiry Date: 2018-08-10T04:00:00Z
Registrar: CSC Corporate Domains, Inc.
Registrar IANA ID: 299
Registrar Abuse Contact Email: domainabuse@cscglobal.com
Registrar Abuse Contact Phone: 8887802723
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited
Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited
Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited
Name Server: NS0-N.DNS.PIPEX.NET
Name Server: NS1-N.DNS.PIPEX.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-05T04:11:16Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR CSC Corporate Domains, Inc.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =nature.com

  PORT 43

  TYPE domain
RegrInfo
DOMAIN

  NAME nature.com

  CHANGED 2016-08-06

  CREATED 1994-08-11

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited
serverTransferProhibited https://icann.org/epp#serverTransferProhibited
serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited

NSERVER

  NS0-N.DNS.PIPEX.NET 158.43.129.78

  NS1-N.DNS.PIPEX.NET 158.43.193.78

  REGISTERED yes

Erreurs

La liste suivante vous montre les fautes d'orthographe possibles des internautes pour le site Web recherché.